Measurement of costs and scales for outcome evaluation in health economic studies of Parkinson's disease.
Identifieur interne : 000523 ( Main/Exploration ); précédent : 000522; suivant : 000524Measurement of costs and scales for outcome evaluation in health economic studies of Parkinson's disease.
Auteurs : Richard Dodel [Allemagne] ; Bengt Jönsson ; Jens Peter Reese ; Yaroslav Winter ; Pablo Martinez-Martin ; Robert Holloway ; Cristina Sampaio ; Evžen Růži Ka ; Graeme Hawthorne ; Wolfgang Oertel ; Werner Poewe [Autriche] ; Glenn Stebbins ; Oliver Rascol ; Christopher G. Goetz ; Anette SchragSource :
- Movement disorders : official journal of the Movement Disorder Society [ 1531-8257 ] ; 2014.
English descriptors
- KwdEn :
- MESH :
- economics : Cost-Benefit Analysis, Parkinson Disease.
- therapy : Parkinson Disease.
- Cost of Illness, Humans, Psychometrics.
Abstract
Health economic studies in Parkinson's disease (PD) have become increasingly common in recent years. Because several methodologies and instruments have been used to assess cost and outcomes in PD, the Movement Disorder Society (MDS) commissioned a Task Force to assess their properties and make recommendations regarding their use. A systematic literature review was conducted to explore the use of those instruments in PD and to determine which should be selected for this review. We assessed approaches to evaluate cost of illness (COI), cost effectiveness, and cost utilities, which include the use of direct (standard gamble, time trade-off. and visual analogue scales) and indirect instruments to measure health status and utilities. No validated instruments/models were identified for the evaluation of COI or cost-effectiveness in patients with PD; therefore, no instruments in this group are recommended. Among utility instruments, only a few of these outcome instruments have been used in the PD population, and only limited psychometric data are available for these instruments with respect to PD. Because psychometric data for further utility instruments in conditions other than PD already exist, the standard gamble and time trade-off methods and the EQ-5D (a European quality-of-life health states instrument) and Health Utility Index instruments met the criteria for scales that are "recommended (with limitations)," but only the EQ-5D has been assessed in detail in PD patients. The MDS Task Force recommends further study of these instruments in the PD population to establish core psychometric properties. For the assessment of COI, the Task Force considers the development of a COI instrument specifically for PD, like that available for Alzheimer's disease.
DOI: 10.1002/mds.25571
PubMed: 23861335
Affiliations:
- Allemagne, Autriche
- District de Giessen, Hesse (Land), Tyrol (Land)
- Innsbruck, Marbourg
- Université de médecine d'Innsbruck
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 000830
- to stream PubMed, to step Curation: 000830
- to stream PubMed, to step Checkpoint: 000531
- to stream Ncbi, to step Merge: 003C52
- to stream Ncbi, to step Curation: 003C52
- to stream Ncbi, to step Checkpoint: 003C52
- to stream Main, to step Merge: 000523
- to stream Main, to step Curation: 000523
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Measurement of costs and scales for outcome evaluation in health economic studies of Parkinson's disease.</title><author><name sortKey="Dodel, Richard" sort="Dodel, Richard" uniqKey="Dodel R" first="Richard" last="Dodel">Richard Dodel</name><affiliation wicri:level="3"><nlm:affiliation>Department of Neurology, Philipps-University Marburg, Marburg, Germany.</nlm:affiliation><country xml:lang="fr">Allemagne</country><wicri:regionArea>Department of Neurology, Philipps-University Marburg, Marburg</wicri:regionArea><placeName><region type="land" nuts="1">Hesse (Land)</region><region type="district" nuts="2">District de Giessen</region><settlement type="city">Marbourg</settlement></placeName></affiliation></author><author><name sortKey="Jonsson, Bengt" sort="Jonsson, Bengt" uniqKey="Jonsson B" first="Bengt" last="Jönsson">Bengt Jönsson</name></author><author><name sortKey="Reese, Jens Peter" sort="Reese, Jens Peter" uniqKey="Reese J" first="Jens Peter" last="Reese">Jens Peter Reese</name></author><author><name sortKey="Winter, Yaroslav" sort="Winter, Yaroslav" uniqKey="Winter Y" first="Yaroslav" last="Winter">Yaroslav Winter</name></author><author><name sortKey="Martinez Martin, Pablo" sort="Martinez Martin, Pablo" uniqKey="Martinez Martin P" first="Pablo" last="Martinez-Martin">Pablo Martinez-Martin</name></author><author><name sortKey="Holloway, Robert" sort="Holloway, Robert" uniqKey="Holloway R" first="Robert" last="Holloway">Robert Holloway</name></author><author><name sortKey="Sampaio, Cristina" sort="Sampaio, Cristina" uniqKey="Sampaio C" first="Cristina" last="Sampaio">Cristina Sampaio</name></author><author><name sortKey="Ruzi Ka, Evzen" sort="Ruzi Ka, Evzen" uniqKey="Ruzi Ka E" first="Evžen" last="Růži Ka">Evžen Růži Ka</name></author><author><name sortKey="Hawthorne, Graeme" sort="Hawthorne, Graeme" uniqKey="Hawthorne G" first="Graeme" last="Hawthorne">Graeme Hawthorne</name></author><author><name sortKey="Oertel, Wolfgang" sort="Oertel, Wolfgang" uniqKey="Oertel W" first="Wolfgang" last="Oertel">Wolfgang Oertel</name></author><author><name sortKey="Poewe, Werner" sort="Poewe, Werner" uniqKey="Poewe W" first="Werner" last="Poewe">Werner Poewe</name><affiliation><country>Autriche</country><placeName><settlement type="city">Innsbruck</settlement><region nuts="2" type="region">Tyrol (Land)</region></placeName><orgName type="university">Université de médecine d'Innsbruck</orgName></affiliation></author><author><name sortKey="Stebbins, Glenn" sort="Stebbins, Glenn" uniqKey="Stebbins G" first="Glenn" last="Stebbins">Glenn Stebbins</name></author><author><name sortKey="Rascol, Oliver" sort="Rascol, Oliver" uniqKey="Rascol O" first="Oliver" last="Rascol">Oliver Rascol</name></author><author><name sortKey="Goetz, Christopher G" sort="Goetz, Christopher G" uniqKey="Goetz C" first="Christopher G" last="Goetz">Christopher G. Goetz</name></author><author><name sortKey="Schrag, Anette" sort="Schrag, Anette" uniqKey="Schrag A" first="Anette" last="Schrag">Anette Schrag</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2014">2014</date><idno type="RBID">pubmed:23861335</idno><idno type="pmid">23861335</idno><idno type="doi">10.1002/mds.25571</idno><idno type="wicri:Area/PubMed/Corpus">000830</idno><idno type="wicri:Area/PubMed/Curation">000830</idno><idno type="wicri:Area/PubMed/Checkpoint">000531</idno><idno type="wicri:Area/Ncbi/Merge">003C52</idno><idno type="wicri:Area/Ncbi/Curation">003C52</idno><idno type="wicri:Area/Ncbi/Checkpoint">003C52</idno><idno type="wicri:Area/Main/Merge">000523</idno><idno type="wicri:Area/Main/Curation">000523</idno><idno type="wicri:Area/Main/Exploration">000523</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Measurement of costs and scales for outcome evaluation in health economic studies of Parkinson's disease.</title><author><name sortKey="Dodel, Richard" sort="Dodel, Richard" uniqKey="Dodel R" first="Richard" last="Dodel">Richard Dodel</name><affiliation wicri:level="3"><nlm:affiliation>Department of Neurology, Philipps-University Marburg, Marburg, Germany.</nlm:affiliation><country xml:lang="fr">Allemagne</country><wicri:regionArea>Department of Neurology, Philipps-University Marburg, Marburg</wicri:regionArea><placeName><region type="land" nuts="1">Hesse (Land)</region><region type="district" nuts="2">District de Giessen</region><settlement type="city">Marbourg</settlement></placeName></affiliation></author><author><name sortKey="Jonsson, Bengt" sort="Jonsson, Bengt" uniqKey="Jonsson B" first="Bengt" last="Jönsson">Bengt Jönsson</name></author><author><name sortKey="Reese, Jens Peter" sort="Reese, Jens Peter" uniqKey="Reese J" first="Jens Peter" last="Reese">Jens Peter Reese</name></author><author><name sortKey="Winter, Yaroslav" sort="Winter, Yaroslav" uniqKey="Winter Y" first="Yaroslav" last="Winter">Yaroslav Winter</name></author><author><name sortKey="Martinez Martin, Pablo" sort="Martinez Martin, Pablo" uniqKey="Martinez Martin P" first="Pablo" last="Martinez-Martin">Pablo Martinez-Martin</name></author><author><name sortKey="Holloway, Robert" sort="Holloway, Robert" uniqKey="Holloway R" first="Robert" last="Holloway">Robert Holloway</name></author><author><name sortKey="Sampaio, Cristina" sort="Sampaio, Cristina" uniqKey="Sampaio C" first="Cristina" last="Sampaio">Cristina Sampaio</name></author><author><name sortKey="Ruzi Ka, Evzen" sort="Ruzi Ka, Evzen" uniqKey="Ruzi Ka E" first="Evžen" last="Růži Ka">Evžen Růži Ka</name></author><author><name sortKey="Hawthorne, Graeme" sort="Hawthorne, Graeme" uniqKey="Hawthorne G" first="Graeme" last="Hawthorne">Graeme Hawthorne</name></author><author><name sortKey="Oertel, Wolfgang" sort="Oertel, Wolfgang" uniqKey="Oertel W" first="Wolfgang" last="Oertel">Wolfgang Oertel</name></author><author><name sortKey="Poewe, Werner" sort="Poewe, Werner" uniqKey="Poewe W" first="Werner" last="Poewe">Werner Poewe</name><affiliation><country>Autriche</country><placeName><settlement type="city">Innsbruck</settlement><region nuts="2" type="region">Tyrol (Land)</region></placeName><orgName type="university">Université de médecine d'Innsbruck</orgName></affiliation></author><author><name sortKey="Stebbins, Glenn" sort="Stebbins, Glenn" uniqKey="Stebbins G" first="Glenn" last="Stebbins">Glenn Stebbins</name></author><author><name sortKey="Rascol, Oliver" sort="Rascol, Oliver" uniqKey="Rascol O" first="Oliver" last="Rascol">Oliver Rascol</name></author><author><name sortKey="Goetz, Christopher G" sort="Goetz, Christopher G" uniqKey="Goetz C" first="Christopher G" last="Goetz">Christopher G. Goetz</name></author><author><name sortKey="Schrag, Anette" sort="Schrag, Anette" uniqKey="Schrag A" first="Anette" last="Schrag">Anette Schrag</name></author></analytic><series><title level="j">Movement disorders : official journal of the Movement Disorder Society</title><idno type="eISSN">1531-8257</idno><imprint><date when="2014" type="published">2014</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Cost of Illness</term><term>Cost-Benefit Analysis (economics)</term><term>Humans</term><term>Parkinson Disease (economics)</term><term>Parkinson Disease (therapy)</term><term>Psychometrics</term></keywords><keywords scheme="MESH" qualifier="economics" xml:lang="en"><term>Cost-Benefit Analysis</term><term>Parkinson Disease</term></keywords><keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Parkinson Disease</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Cost of Illness</term><term>Humans</term><term>Psychometrics</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Health economic studies in Parkinson's disease (PD) have become increasingly common in recent years. Because several methodologies and instruments have been used to assess cost and outcomes in PD, the Movement Disorder Society (MDS) commissioned a Task Force to assess their properties and make recommendations regarding their use. A systematic literature review was conducted to explore the use of those instruments in PD and to determine which should be selected for this review. We assessed approaches to evaluate cost of illness (COI), cost effectiveness, and cost utilities, which include the use of direct (standard gamble, time trade-off. and visual analogue scales) and indirect instruments to measure health status and utilities. No validated instruments/models were identified for the evaluation of COI or cost-effectiveness in patients with PD; therefore, no instruments in this group are recommended. Among utility instruments, only a few of these outcome instruments have been used in the PD population, and only limited psychometric data are available for these instruments with respect to PD. Because psychometric data for further utility instruments in conditions other than PD already exist, the standard gamble and time trade-off methods and the EQ-5D (a European quality-of-life health states instrument) and Health Utility Index instruments met the criteria for scales that are "recommended (with limitations)," but only the EQ-5D has been assessed in detail in PD patients. The MDS Task Force recommends further study of these instruments in the PD population to establish core psychometric properties. For the assessment of COI, the Task Force considers the development of a COI instrument specifically for PD, like that available for Alzheimer's disease.</div></front></TEI><affiliations><list><country><li>Allemagne</li><li>Autriche</li></country><region><li>District de Giessen</li><li>Hesse (Land)</li><li>Tyrol (Land)</li></region><settlement><li>Innsbruck</li><li>Marbourg</li></settlement><orgName><li>Université de médecine d'Innsbruck</li></orgName></list><tree><noCountry><name sortKey="Goetz, Christopher G" sort="Goetz, Christopher G" uniqKey="Goetz C" first="Christopher G" last="Goetz">Christopher G. Goetz</name><name sortKey="Hawthorne, Graeme" sort="Hawthorne, Graeme" uniqKey="Hawthorne G" first="Graeme" last="Hawthorne">Graeme Hawthorne</name><name sortKey="Holloway, Robert" sort="Holloway, Robert" uniqKey="Holloway R" first="Robert" last="Holloway">Robert Holloway</name><name sortKey="Jonsson, Bengt" sort="Jonsson, Bengt" uniqKey="Jonsson B" first="Bengt" last="Jönsson">Bengt Jönsson</name><name sortKey="Martinez Martin, Pablo" sort="Martinez Martin, Pablo" uniqKey="Martinez Martin P" first="Pablo" last="Martinez-Martin">Pablo Martinez-Martin</name><name sortKey="Oertel, Wolfgang" sort="Oertel, Wolfgang" uniqKey="Oertel W" first="Wolfgang" last="Oertel">Wolfgang Oertel</name><name sortKey="Rascol, Oliver" sort="Rascol, Oliver" uniqKey="Rascol O" first="Oliver" last="Rascol">Oliver Rascol</name><name sortKey="Reese, Jens Peter" sort="Reese, Jens Peter" uniqKey="Reese J" first="Jens Peter" last="Reese">Jens Peter Reese</name><name sortKey="Ruzi Ka, Evzen" sort="Ruzi Ka, Evzen" uniqKey="Ruzi Ka E" first="Evžen" last="Růži Ka">Evžen Růži Ka</name><name sortKey="Sampaio, Cristina" sort="Sampaio, Cristina" uniqKey="Sampaio C" first="Cristina" last="Sampaio">Cristina Sampaio</name><name sortKey="Schrag, Anette" sort="Schrag, Anette" uniqKey="Schrag A" first="Anette" last="Schrag">Anette Schrag</name><name sortKey="Stebbins, Glenn" sort="Stebbins, Glenn" uniqKey="Stebbins G" first="Glenn" last="Stebbins">Glenn Stebbins</name><name sortKey="Winter, Yaroslav" sort="Winter, Yaroslav" uniqKey="Winter Y" first="Yaroslav" last="Winter">Yaroslav Winter</name></noCountry><country name="Allemagne"><region name="Hesse (Land)"><name sortKey="Dodel, Richard" sort="Dodel, Richard" uniqKey="Dodel R" first="Richard" last="Dodel">Richard Dodel</name></region></country><country name="Autriche"><region name="Tyrol (Land)"><name sortKey="Poewe, Werner" sort="Poewe, Werner" uniqKey="Poewe W" first="Werner" last="Poewe">Werner Poewe</name></region></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000523 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000523 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Santé
|area= MovDisordV3
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:23861335
|texte= Measurement of costs and scales for outcome evaluation in health economic studies of Parkinson's disease.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:23861335" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a MovDisordV3
| This area was generated with Dilib version V0.6.23. |  |